• Erratum to ¡®Correspondence on Letter regarding ¡°Evidence-based hyponatremia management in liver di...

• Baek Seon-Ha

• Ryu Ji-Young, Kim Se-Joong

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 134 ~ 134

• Recent updates on pharmacologic therapy in nonalcoholic fatty liver disease

• Chang Young

• Jeong Soung-Won, Jang Jae-Young

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 129 ~ 133

• Correspondence on Letter regarding ¡°Waiting for the changes after the adoption of steatotic liver d...

• Eileen L. Yoon

• Jun Dae-Won

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 126 ~ 128

• Correspondence on Letter regarding ¡°Assessing the performance of ChatGPT in answering questions reg...

• Yee Hui Yeo

• Ju Dong Yang

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 124 ~ 125

• Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and M...

• Shuhei Fukunaga

• Michita Mukasa, Dan Nakano, Tsubasa Tsutsumi, Takumi Kawaguchi

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 121 ~ 123

• Letter regarding ¡°Waiting for the changes after the adoption of steatotic liver disease¡±

• Kuo Chao Yew

• Sunny H. Wong, Vincent Wai-Sun Wong, Hazel H. Oon

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 118 ~ 120

• Letter 2 regarding ¡°Assessing the performance of ChatGPT in answering questions regarding cirrhosis...

• Yiwen Zhang

• Liwei Wu, Zepeng Mu, Linlin Ren, Ying Chen, Hanyun Liu, Lili Xu, Yangang Wang, Yaxing...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 113 ~ 117

• Letter 1 regarding ¡°Assessing the performance of ChatGPT in answering questions regarding cirrhosis...

• Hinpetch Daungsupawong

• Viroj Wiwanitkit

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 111 ~ 112

• Letter regarding ¡°Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell l...

• Chi Hsiao

• Yung-Po Liaw

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 109 ~ 110

• Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)i...

• Ying-Nan Tsai

• Jia-Ling Wu, Cheng-Hao Tseng, Tzu-Haw Chen, Yi-Ling Wu, Chieh-Chang Chen, Yu-Jen Fang, Tze...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 98 ~ 108

• Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as...

• Yingzhou Shi

• Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li,&nb...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 80 ~ 97

• Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: ...

• Ming-Ying Lu

• Chung-Feng Huang, Chao-Hung Hung, Chi?Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng,&nbs...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 64 ~ 79

• Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or te...

• Hong Hye-Yeon

• Choi Won-Mook, Lee Dan-Bi, Shim Ju-Hyun, Kim Kang-Mo , Lim Young-Suk, Lee Han-Chu, Choi Jo...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 49 ~ 63

• Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensi...

• Ahn Soo-Min

• Jeong Sook-Hyang, Cho Eun-Ju, Lee Kyoung-Bun, Kim Gil-Hyang, Kim Hae-Ryoung

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 37 ~ 48

• Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement...

• Pin-Nan Cheng

• Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chan...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 16 ~ 36

• Recent advances in the management of hepatocellular carcinoma

• Kamya Sankar

• Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar,...

• Clinical and Molecular Hepatology   2024  Volume.30  No.1 1 ~ 15